8
582
J . Org. Chem. 1997, 62, 8582-8585
Der a ilin g Deh yd r oqu in a te Syn th a se by
In tr od u cin g a Sta bilizin g Ster eoelectr on ic
Effect in a Rea ction In ter m ed ia te
Sch em e 1. Mech a n ism for th e Deh yd r oqu in a te
a
Syn th a se Ca ta lyzed Rea ction
†
‡
,†
Emily J . Parker, J ohn R. Coggins, and Chris Abell*
University Chemical Laboratory, Lensfield Road,
Cambridge CB2 1EW, England, and Department of
Biochemistry, University of Glasgow,
Glasgow G12 8QQ, Scotland
Received J uly 17, 1997
3
-Dehydroquinate synthase (E.C. 4.6.1.3) catalyses the
conversion of 2-deoxy-D-arabino-heptulosonic acid 7-phos-
phate (DAHP) (1) into 3-dehydroquinate 6. This is the
second step on the shikimate pathway to the aromatic
amino acids.1 The mechanism of this transformation
2
(
Scheme 1) was first proposed by Sprinson and substan-
3
tially confirmed by Knowles.
The complexity of the dehydroquinate synthase mech-
anism raised the question of how the oxidation and
reduction, phosphate cleavage, and aldol ring closure
reactions could be catalyzed by a small monomeric
enzyme. A series of elegant studies suggested that the
inherent reactivity of the various enzymic intermediates
reduced the role of the enzyme to little more than that
a
When DAHP 1 is the substrate only dehydroquinate 6 is
formed, and the intermediate enolpyranose 3 is cyclized on the
enzyme. When 3 is generated by deprotection of 4, a mixture of 6
4
of an “internal cycling dehydrogenase”. For example,
and 7 is formed nonenzymatically.7 The solid arrows indicate
evidence was presented to show that the base responsible
for the deprotonation of the intermediate 2 at C-6 was
the substrate phosphate dianion.5
enzymatic reactions, and the dotted arrows are nonenzymatic
transformations.
properties.9 Using a mixture of (3R)- and (3S)-3-fluo-
The involvement of the enzyme in the conversion of
the enol pyranose 3 to dehydroquinate 6 has also been
questioned. Photochemical removal of the o-nitrobenzyl
protecting group from 4 was initially reported to result
in complete conversion of 3 to dehydroquinate in the
absence of enzyme.6 Furthermore, the cyclization was
shown to proceed through the same chairlike transition
state as had been established for the enzyme-catalyzed
aldol step. This led to the suggestion that the enolpyra-
nose 3 was the product of the enzyme reaction. Upon
subsequent reinvestigation of this nonenzymatic reaction,
it was found that the reaction of 3 was not entirely
stereospecific with 2.5-4% of 1-epi-dehydroquinate 7 also
10
roDAHP (8 and 11) generated by DAHP synthase, we
observed that the (3R)-isomer was very rapidly converted
to (6R)-6-fluorodehydroquinate (10) before the (3S)-3-
fluoroDAHP was slowly converted to (6S)-6-fluorodehy-
droquinate (13) and an unknown product. We now report
on a detailed study of this reaction and identify the
unknown product as (6S)-1-epi-6-fluorodehydroquinate
(14). The formation of 13 and 14 appears to be from a
common intermediate 12 after its release from the
enzyme (Scheme 2).
(3R)-3-FluoroDAHP (8) and (3S)-3-fluoroDAHP (11)
were separately synthesized enzymatically from eryth-
rose 4-phosphate and (E)-3-fluoroPEP and (Z)-3-fluo-
7
being formed. As this product is not observed in the
11
roPEP, respectively, using DAHP synthase. The fluo-
enzymatic reaction, the role of the enzyme in guiding the
conversion of 3 to 6 was reinstated. We now show that
a modification of the enol pyranose intermediate by
putting an axial fluorine next to the hemiketal center
roDAHPs were then used in kinetic studies as substrate
analogues for dehydroquinate synthase. The kinetic
constants were determined in a coupled spectrophoto-
metric assay by using an excess of E. coli dehydro-
(e.g., in 12) promotes the dissociation of the enol pyranose
quinase to convert the 6-fluorodehydroquinates to the
intermediate from the enzyme, so that it cyclizes in
solution.
12,13
corresponding 6-fluorodehydroshikimates,
after first
confirming that (6R)- and (6S)-6-fluorodehydroquinate
are good substrates for dehydroquinase.
We have previously developed an enzymatic synthesis
8
of 6-fluoroshikimates as part of a study of their antibiotic
(
8) Duggan, P. J .; Parker, E.; Coggins, J .; Abell, C. Bioorg. Med.
*
To whom correspondence should be addressed. Tel.: +44-1223-
Chem. Lett. 1995, 5, 2347-2352.
3
36405. FAX: +44-1223-336362. E-mail: ca26@cam.ac.uk.
(9) Davies, G. M.; Barrettbee, K. J .; J ude, D. A.; Lehan, M.; Nichols,
W. W.; Pinder, P. E.; Thain, J . L.; Watkins, W. J .; Wilson, R. G.
Antimicrob. Agents Chemother. 1994, 38, 403-406.
(10) Pilch, P. F.; Somerville, R. L. Biochemistry 1976, 15, 5315-
5320.
†
University Chemical Laboratory.
University of Glasgow.
‡
(
1) Bentley, R. CRC Crit. Rev. Biochem. 1990, 25, 307-384.
(2) Sprinson, D. B.; Rothschild, M.; Sprecher, M. J . Biol. Chem. 1963,
2
38, 3170-3175.
(11) Details of the preparation and purification of 8 and 11, the
1
9
(
3) Knowles, J . Aldrichim. Acta 1989, 22, 59-66.
kinetic data for the enzymatic conversions, and F NMR spectra of
10, 13, and 14 are available as Supporting Information.
(12) Dehydroquinate synthase was purified according to the method
of: Frost, J . W.; Bender, J . L.; Kadonaga, J . T.; Knowles, J . R.
Biochemistry 1984, 23, 4470-4475.
(4) Bender, S. L.; Mehdi, S.; Knowles, J . R. Biochemistry 1989, 28,
7
1
1
5
555-7560.
5) Widlanski, T.; Bender, S. L.; Knowles, J . R. J . Am. Chem. Soc.
989, 111, 2299-2300.
6) Bartlett, P. A.; Satake, K. J . Am. Chem. Soc. 1988, 110, 1628-
630.
(
(
(13) However, these findings are at variance with the work of Le
app
Marechal who reported that the K
M
for 8 and 11 was in the range
(7) Bartlett, P. A.; Mclaren, K. L.; Marx, M. A. J . Org. Chem. 1994,
40-60 µM and the Vmax values were in the order 1 >11 > 8. Le
Marechal, P.; Froussios, C.; Azerad, R. Biochimie 1986, 68, 1211-1215.
9, 2082-2085.
S0022-3263(97)01306-6 CCC: $14.00 © 1997 American Chemical Society